510(k) K902661
K902661 is an FDA 510(k) premarket notification submitted by Baxter Healthcare Corp for the device "BARTELS HERPES SIMPLEX VIR FLU MONO ANTIB HSV-1&2". The FDA issued a decision of Substantially Equivalent on July 31, 1990. The device falls under product code GQL (Antisera, Fluorescent, Herpesvirus Hominis 1,2), a Class II device regulated under 21 CFR 866.3305. Baxter Healthcare Corp has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 31, 1990
- Date Received
- June 18, 1990
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antisera, Fluorescent, Herpesvirus Hominis 1,2
- Device Class
- Class II
- Regulation Number
- 866.3305
- Review Panel
- MI
- Submission Type